Registry review maps a growing field of mild cognitive impairment trials
The study describes what researchers are testing, with a large share of small trials and a strong emphasis on non-drug approaches.
Based on the published abstract. The full paper may contain additional methods, results and limitations.
The 30-second takeaway
This study maps the organization and focus of registered research on mild cognitive impairment. Non-drug approaches were prominent, and many trials were small. The findings describe research priorities and gaps, but growing registration numbers do not establish better cognitive outcomes or a lower chance of developing dementia.
Registrations describe planned or recorded studies, not necessarily completed results. The abstract reports limited data sharing and does not provide evidence that any listed intervention improves cognition or prevents dementia.
What researchers found
Trials with fewer than 100 participants
Descriptive share of included registrations through December 2024; no treatment comparator or patient-outcome estimate.
What the researchers counted
The researchers removed duplicate records and extracted information about study design, location, sponsorship, participant numbers and intervention type. Their analysis describes the contents of a trial registry, including studies at different stages of development.
Research interest is not an outcome
Brain stimulation, cognitive approaches, diet and exercise were common non-drug research topics. The authors also highlighted combined traditional and computer-assisted cognitive training as an emerging direction, but the abstract supplies no outcome comparison demonstrating its effectiveness.
The original publication
Clinical trial characteristics and intervention profiles for mild cognitive impairment: a systematic analysis of WHO ICTRP registry.
Sun Y, Zhang F, Zhou Y et al.
Front Pharmacol · 2026
- PubMed ID
- 41635483
- Record checked
AI-assisted research and writing. This explains one selected publication; it is not a complete review of everything known. Our approach.
One more question, understood.
Keep track of the research you’ve explored.